Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes

References

• Visaggi P, Savarino E, Sciume G, et al. Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults. Ther Adv Gastroenterol. 2021;14:1756284820980860. doi:10.1177/1756284820980860
   Web of Science ®Google Scholar
• de Bortoli N, Visaggi P, Penagini R, et al. The 1st EoETALY consensus on the diagnosis and management of eosinophilic esophagitis - definition, clinical presentation and diagnosis. Digestive Liver Dis. 2024;2004:1.
   Google Scholar
• Visaggi P, Barberio B, Del Corso G, et al. Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis. Gut. 2023;72:2019–2030. doi:10.1136/gutjnl-2023-329873
   PubMed Web of Science ®Google Scholar
• Kliewer KL, Gonsalves N, Dellon ES, et al. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol. 2023;8(5):408–421. doi:10.1016/S2468-1253(23)00012-2
   PubMed Web of Science ®Google Scholar
• Marasco G, Visaggi P, Vassallo M, et al. Current and novel therapies for eosinophilic gastrointestinal diseases. Int J Mol Sci. 2023;24(20):15165. doi:10.3390/ijms242015165
   PubMed Web of Science ®Google Scholar
• Dellon ES, Woosley JT, Arrington A, et al. Rapid recurrence of eosinophilic esophagitis activity after successful treatment in the observation phase of a randomized, double-blind, double-dummy trial. Clin Gastroenterol Hepatol. 2020;18(7):1483–92.e2. doi:10.1016/j.cgh.2019.08.050
   PubMed Web of Science ®Google Scholar
• Molina-Infante J, Rodriguez-Sanchez J, Martinek J, et al. Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis. Am J Gastroenterol. 2015;110(11):1567–1575. doi:10.1038/ajg.2015.314
   PubMed Web of Science ®Google Scholar
• Eluri S, Runge TM, Hansen J, et al. Diminishing effectiveness of long-term maintenance topical steroid therapy in PPI non-responsive eosinophilic esophagitis. Clin Translat Gastroenterol. 2017;8(6):e97. doi:10.1038/ctg.2017.27
   PubMedGoogle Scholar
• Visaggi P, Ghisa M, Barberio B, et al. Treatment trends for eosinophilic esophagitis and the other eosinophilic gastrointestinal diseases: systematic review of clinical trials. Digestive Liver Dis. 2022;2022:1.
   Google Scholar
• Arnim UV, Biedermann L, Aceves SS, et al. Monitoring patients with eosinophilic esophagitis in routine clinical practice - international expert recommendations. Clin Gastroenterol Hepatol. 2022;21:2526–2533. doi:10.1016/j.cgh.2022.12.018
   PubMed Web of Science ®Google Scholar
• de Bortoli N, Visaggi P, Penagini R, et al. The 1st EoETALY consensus on the diagnosis and management of eosinophilic esophagitis-current treatment and monitoring. Digestive Liver Dis. 2024;2024:1.
   Google Scholar
• Dellon ES, Gupta SK. A conceptual approach to understanding treatment response in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17(11):2149–2160. doi:10.1016/j.cgh.2019.01.030
   PubMed Web of Science ®Google Scholar
• Ma C, Schoepfer AM, Dellon ES, et al. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). J Allergy Clin Immunol. 2022;149(2):659–670. doi:10.1016/j.jaci.2021.07.001
   PubMed Web of Science ®Google Scholar
• Chang JW, Yeow RY, Waljee AK, Rubenstein JH. Systematic review and meta-regressions: management of eosinophilic esophagitis requires histologic assessment. Diseas Esophag. 2018;31(8). doi:10.1093/dote/doy049
   Web of Science ®Google Scholar
• Safroneeva E, Straumann A, Coslovsky M, et al. Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis. Gastroenterology. 2016;150(3):581–90.e4. doi:10.1053/j.gastro.2015.11.004
   PubMed Web of Science ®Google Scholar
• Safroneeva E, Pan Z, King E, et al. Long-lasting dissociation of esophageal eosinophilia and symptoms after dilation in adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2022;20(4):766–75.e4. doi:10.1016/j.cgh.2021.05.049
   PubMed Web of Science ®Google Scholar
• Visaggi P, Savarino E, Del Corso G, et al. Six-food elimination diet is less effective during pollen season in adults with eosinophilic esophagitis sensitized to pollens. Am J Gastroenterol. 2023;118:1957–1962. doi:10.14309/ajg.0000000000002357
   PubMedGoogle Scholar
• Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489–495. doi:10.1136/gutjnl-2011-301817
   PubMed Web of Science ®Google Scholar
• Taft TH, Carlson DA, Simons M, et al. Esophageal hypervigilance and symptom-specific anxiety in patients with eosinophilic esophagitis. Gastroenterology. 2021;161(4):1133–1144. doi:10.1053/j.gastro.2021.06.023
   PubMed Web of Science ®Google Scholar
• Carlson DA, Shehata C, Gonsalves N, et al. Esophageal dysmotility is associated with disease severity in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2021;2021:1.
   Google Scholar
• Visaggi P, Ghisa M, Marabotto E, et al. Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications. Esophagus. 2022;2022:1.
   Google Scholar
• Naik RD, Patel DA. Unlocking the mind might be critical in management of eosinophilic esophagitis: expanding beyond drugs, dilation. and Diet Gastroenterol. 2021;161(4):1099–1101. doi:10.1053/j.gastro.2021.07.032
   PubMed Web of Science ®Google Scholar
• Savarino E, Di Pietro M, Bredenoord AJ, et al. Use of the functional lumen imaging probe in clinical esophagology. Off J Am Coll Gastroenterol. 2020;115(11):1.
   PubMed Web of Science ®Google Scholar
• Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7(10):1055–1061. doi:10.1016/j.cgh.2009.06.023
   PubMed Web of Science ®Google Scholar
• Dellon ES, Hirano I. Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology. 2018;154(2):319–32.e3. doi:10.1053/j.gastro.2017.06.067
   PubMed Web of Science ®Google Scholar
• Arias A, Perez-Martinez I, Tenias JM, Lucendo AJ. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43(1):3–15. doi:10.1111/apt.13441
   PubMed Web of Science ®Google Scholar
• Mohammad AA, Wu SZ, Ibrahim O, et al. Prevalence of atopic comorbidities in eosinophilic esophagitis: a case-control study of 449 patients. J Am Acad Dermatol. 2017;76(3):559–560. doi:10.1016/j.jaad.2016.08.068
   PubMed Web of Science ®Google Scholar
• González-Cervera J, Arias Á, Redondo-González O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ. Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Anna Allergy Asthma Immunol. 2017;118(5):582–90.e2. doi:10.1016/j.anai.2017.02.006
   PubMed Web of Science ®Google Scholar
• Sciumè GD, Visaggi P, Sostilio A, et al. Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations. Miner Gastroent. 2022;68(1):23–39. doi:10.23736/S2724-5985.20.02807-X
   Google Scholar
• Araujo IK, Shehata C, Hirano I, et al. The severity of reduced esophageal distensibility parallels eosinophilic esophagitis disease duration. Clin Gastroenterol Hepatol. 2023;22:513–522.e1. doi:10.1016/j.cgh.2023.04.027
   PubMed Web of Science ®Google Scholar
• Muir AB, Ackerman SJ, Pan Z, et al. Esophageal remodeling in eosinophilic esophagitis: relationships to luminal captured biomarkers of inflammation and periostin. J Allergy Clin Immunol. 2022;150:649–656.e5. doi:10.1016/j.jaci.2022.03.022
   PubMed Web of Science ®Google Scholar
• Chang NC, Thakkar KP, Ketchem CJ, Eluri S, Reed CC, Dellon ES. A gap in care leads to progression of fibrosis in eosinophilic esophagitis patients. Clin Gastroenterol Hepatol. 2022;20(8):1701–8.e2. doi:10.1016/j.cgh.2021.10.028
   PubMed Web of Science ®Google Scholar
• Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(5):1084–92.e1. doi:10.1016/j.jaci.2014.07.021
   PubMed Web of Science ®Google Scholar
• Hudgens S, Evans C, Phillips E, Hill M. Psychometric validation of the dysphagia symptom questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension. J Patient Rep Outcomes. 2017;1(1):3. doi:10.1186/s41687-017-0006-5
   PubMedGoogle Scholar
• Schoepfer AM, Straumann A, Panczak R, et al. Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. Gastroenterology. 2014;147(6):1255–66.e21. doi:10.1053/j.gastro.2014.08.028
   PubMed Web of Science ®Google Scholar
• Warners MJ, Hindryckx P, Levesque BG, et al. Systematic review: disease activity indices in eosinophilic esophagitis. Am J Gastroenterol. 2017;112(11):1658–1669. doi:10.1038/ajg.2017.363
   PubMed Web of Science ®Google Scholar
• Visaggi P, Del Corso G, Svizzero FB, et al. Artificial intelligence tools for the diagnosis of eosinophilic esophagitis in adults reporting dysphagia: development, external validation, and software creation for point-of-care use. J Aller Clin Immunol Pract. 2023;12:1008–1016.e1. doi:10.1016/j.jaip.2023.12.031
   PubMed Web of Science ®Google Scholar
• Taft TH, Triggs JR, Carlson DA, et al. Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther. 2018;47(9):1270–1277. doi:10.1111/apt.14605
   PubMed Web of Science ®Google Scholar
• Alexander R, Alexander JA, Ravi K, et al. Measurement of observed eating behaviors in patients with active and inactive eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17(11):2371–2373. doi:10.1016/j.cgh.2018.12.011
   PubMed Web of Science ®Google Scholar
• Ghisa M, Laserra G, Marabotto E, et al. Achalasia and obstructive motor disorders are not uncommon in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2020;2020:1.
   Google Scholar
• Frazzoni M, Penagini R, Frazzoni L, et al. Role of reflux in the pathogenesis of eosinophilic esophagitis: comprehensive appraisal with off- and on PPI impedance-pH monitoring. Am J Gastroenterol. 2019;114(10):1606–1613. doi:10.14309/ajg.0000000000000379
   PubMed Web of Science ®Google Scholar
• Visaggi P, Ghisa M, Barberio B, Marabotto E, de Bortoli N, Savarino E. Systematic review: esophageal motility patterns in patients with eosinophilic esophagitis. Digestive Liver Dis. 2022;54:1143–1152. doi:10.1016/j.dld.2022.01.003
   Web of Science ®Google Scholar
• Visaggi P, Mariani L, Svizzero FB, et al. Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease. Esophagus. 2022;19:525–534. doi:10.1007/s10388-022-00933-6
   PubMed Web of Science ®Google Scholar
• Carlson DA, Gyawali CP, Khan A, et al. Classifying esophageal motility by FLIP panometry: a study of 722 subjects with manometry. Am J Gastroenterol. 2021;116(12):2357–2366. doi:10.14309/ajg.0000000000001532
   PubMed Web of Science ®Google Scholar
• Carlson DA, Kou W, Lin Z, et al. Normal values of esophageal distensibility and distension-induced contractility measured by functional luminal imaging probe panometry. Clin Gastroenterol Hepatol. 2019;17(4):674–81.e1. doi:10.1016/j.cgh.2018.07.042
   PubMed Web of Science ®Google Scholar
• Nicodème F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11(9):1101–7.e1. doi:10.1016/j.cgh.2013.03.020
   PubMed Web of Science ®Google Scholar
• Moosavi S, Shehata C, Kou W, et al. Measuring esophageal compliance using functional lumen imaging probe to assess remodeling in eosinophilic esophagitis. Neurogastroenterol Motil. 2023;35(4):e14525. doi:10.1111/nmo.14525
   PubMed Web of Science ®Google Scholar
• Chen JW, Pandolfino JE, Lin Z, et al. Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis. Endoscopy. 2016;48(9):794–801. doi:10.1055/s-0042-107340
   PubMedGoogle Scholar
• Carlson DA, Hirano I, Gonsalves N, et al. A physiomechanical model of esophageal function in eosinophilic esophagitis. Gastroenterology. 2023;165(3):552–63.e4. doi:10.1053/j.gastro.2023.05.031
   PubMed Web of Science ®Google Scholar
• Carlson DA, Hirano I, Gonsalves N, et al. Composite score of physiomechanical esophageal function using functional lumen imaging probe panometry in eosinophilic esophagitis. Gastrointest Endosc. 2024;99(4):499–510.e1. doi:10.1016/j.gie.2023.10.048
   PubMed Web of Science ®Google Scholar
• Savarino E, Bhatia S, Roman S, et al. Achalasia. Nat Rev Dis Primers. 2022;8(1):28. doi:10.1038/s41572-022-00356-8
   PubMedGoogle Scholar
• Mari A, Savarino E. Advances on neurogastroenterology and motility disorders: pathophysiology, diagnostics and management. J Clin Med. 2022;11(10). doi:10.3390/jcm11102911
   Web of Science ®Google Scholar
• Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(©). Neurogastroenterol Motil. 2021;33(1):e14058. doi:10.1111/nmo.14058
   PubMed Web of Science ®Google Scholar
• Bassett J, Maydonovitch C, Perry J, Sobin L, Osgard E, Wong R. Prevalence of esophageal dysmotility in a cohort of patients with esophageal biopsies consistent with eosinophilic esophagitis. Diseas Esophag. 2009;22(6):543–548. doi:10.1111/j.1442-2050.2009.00949.x
   PubMed Web of Science ®Google Scholar
• Savarino EV, Tolone S, Bartolo O, et al. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon. Aliment Pharmacol Ther. 2016;44(5):522–530. doi:10.1111/apt.13718
   PubMed Web of Science ®Google Scholar
• Visaggi P, Ghisa M, Del Corso G, et al. Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction. Aliment Pharmacol Ther. 2022;56:606–613. doi:10.1111/apt.17101
   PubMed Web of Science ®Google Scholar
• Sanagapalli S, McGuire J, Leong RW, et al. The clinical relevance of manometric esophagogastric junction outflow obstruction can be determined using rapid drink challenge and solid swallows. Am J Gastroenterol. 2021;116(2):280–288. doi:10.14309/ajg.0000000000000988
   PubMed Web of Science ®Google Scholar
• Ang D, Misselwitz B, Hollenstein M, et al. Diagnostic yield of high-resolution manometry with a solid test meal for clinically relevant, symptomatic oesophageal motility disorders: serial diagnostic study. Lancet Gastroenterol Hepatol. 2017;2(9):654–661. doi:10.1016/S2468-1253(17)30148-6
   PubMed Web of Science ®Google Scholar
• Lucendo AJ. Motor disturbances participate in the pathogenesis of eosinophilic oesophagitis, beyond the fibrous remodelling of the oesophagus. Aliment Pharmacol Ther. 2006;24(8):1264–1267. doi:10.1111/j.1365-2036.2006.03109.x
   PubMed Web of Science ®Google Scholar
• Hempel SL, Elliott DE. Chest pain in an aspirin-sensitive asthmatic patient. Eosinophilic esophagitis causing esophageal dysmotility. Chest. 1996;110(4):1117–1120. doi:10.1378/chest.110.4.1117
   PubMed Web of Science ®Google Scholar
• Savarino E, Gemignani L, Zentilin P, et al. Achalasia with dense eosinophilic infiltrate responds to steroid therapy. Clin Gastroenterol Hepatol. 2011;9(12):1104–1106. doi:10.1016/j.cgh.2011.08.002
   PubMed Web of Science ®Google Scholar
• Hiremath G, Sun L, Collins MH, et al. Esophageal epithelium and lamina propria are unevenly involved in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2023;21(11):2807–16.e3. doi:10.1016/j.cgh.2023.03.014
   PubMed Web of Science ®Google Scholar
• Dhar A, Haboubi HN, Attwood SE, et al. British society of gastroenterology (BSG) and British society of paediatric gastroenterology, hepatology and nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022;71(8):1459–1487. doi:10.1136/gutjnl-2022-327326
   PubMed Web of Science ®Google Scholar
• Hirano I, Chan ES, Rank MA, et al. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Gastroenterology. 2020;158(6):1776–1786. doi:10.1053/j.gastro.2020.02.038
   PubMed Web of Science ®Google Scholar
• Levine DS, Reid BJ. Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc. 1991;37(3):332–337. doi:10.1016/S0016-5107(91)70726-8
   PubMed Web of Science ®Google Scholar
• van Rhijn BD, Warners MJ, Curvers WL, et al. Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability. Endoscopy. 2014;46(12):1049–1055. doi:10.1055/s-0034-1377781
   PubMed Web of Science ®Google Scholar
• Dellon ES, Cotton CC, Gebhart JH, et al. Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment. Clin Gastroenterol Hepatol. 2016;14(1):31–39. doi:10.1016/j.cgh.2015.08.040
   PubMed Web of Science ®Google Scholar
• Salek J, Clayton F, Vinson L, et al. Endoscopic appearance and location dictate diagnostic yield of biopsies in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2015;41(12):1288–1295. doi:10.1111/apt.13201
   PubMed Web of Science ®Google Scholar
• Kim H, Vance R, Shaheen N, Dellon E. The Prevalence and Diagnostic Utility of Endoscopic Features of Eosinophilic Esophagitis: a Meta-Analysis. Clin Gastroenterol Hepatol. 2012;10:988–96.e5. doi:10.1016/j.cgh.2012.04.019
   PubMed Web of Science ®Google Scholar
• Moawad FJ, Robinson CL, Veerappan GR, Summers TA, Maydonovitch CL, Wong R. The tug sign: an endoscopic feature of eosinophilic esophagitis. Am J Gastroenterol. 2013;108(12):1938–1939. doi:10.1038/ajg.2013.252
   PubMed Web of Science ®Google Scholar
• Dellon ES, Gebhart JH, Higgins LL, Hathorn KE, Woosley JT, Shaheen NJ. The esophageal biopsy ”pull” sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video). Gastrointest Endosc. 2016;83(1):92–100. doi:10.1016/j.gie.2015.05.046
   PubMed Web of Science ®Google Scholar
• Ishimura N, Sumi S, Okada M, et al. Ankylosaurus back sign: novel endoscopic finding in esophageal eosinophilia patients indicating proton pump inhibitor response. Endosc Int Open. 2018;6(2):E165–e72. doi:10.1055/s-0043-122882
   PubMedGoogle Scholar
• Gregory E, Fort Gasia M, Gui X, Ghosh S, Iacucci M. High-definition-iSCAN virtual chromoendoscopy has high sensitivity and specificity for the diagnosis of eosinophilic esophagitis. Endosc Int Open. 2017;5(7):E613–e21. doi:10.1055/s-0043-111591
   PubMedGoogle Scholar
• Ichiya T, Tanaka K, Rubio CA, Hammar U, Schmidt PT. Evaluation of narrow-band imaging signs in eosinophilic and lymphocytic esophagitis. Endoscopy. 2017;49(5):429–437. doi:10.1055/s-0043-101685
   PubMed Web of Science ®Google Scholar
• Cotton CC, Woosley JT, Moist SE, et al. Determination of a treatment response threshold for the eosinophilic esophagitis endoscopic reference score. Endoscopy. 2022;54(7):635–643. doi:10.1055/a-1675-7860
   PubMedGoogle Scholar
• EMA. Budesonide orally disintegrating tablet EMA approval; 2023.
   Google Scholar
• EMA. Dupilumab Approval EMA; 2023. https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_en.pdf. Accessed July 22, 2024.
   Google Scholar
• FDA. Budesonide oral suspension FDA approval; 2024.
   Google Scholar
• FDA. Dupilumab FDA Approval; 2023.
   Google Scholar
• Lucendo AJ, Miehlke S, Schlag C, et al. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology. 2019;157(1):74–86.e15. doi:10.1053/j.gastro.2019.03.025
   PubMed Web of Science ®Google Scholar
• Straumann A, Lucendo AJ, Miehlke S, et al. Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis. Gastroenterology. 2020;159(5):1672–85.e5. doi:10.1053/j.gastro.2020.07.039
   PubMed Web of Science ®Google Scholar
• Hirano I, Collins MH, Katzka DA, et al. Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial. Clin Gastroenterol Hepatol. 2022;20(3):525–34.e10. doi:10.1016/j.cgh.2021.04.022
   PubMed Web of Science ®Google Scholar
• Dellon ES, Collins MH, Katzka DA, et al. Long-term treatment of eosinophilic esophagitis with budesonide oral suspension. Clin Gastroenterol Hepatol. 2021;19:699–706.e4. doi:10.1016/j.cgh.2020.03.060
   PubMed Web of Science ®Google Scholar
• Rothenberg ME, Dellon ES, Collins MH, et al. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2023;8(11):990–1004. doi:10.1016/S2468-1253(23)00204-2
   PubMed Web of Science ®Google Scholar
• van Rhijn BD, Weijenborg PW, Verheij J, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12(11):1815–23.e2. doi:10.1016/j.cgh.2014.02.037
   PubMed Web of Science ®Google Scholar
• Visaggi P, Svizzero FB, Del Corso G, Bellini M, Savarino E, de Bortoli N. Efficacy of Second PPI course following steroid-induced remission in eosinophilic esophagitis refractory to initial PPI therapy. Am J Gastroenterol. 2022;117:1702–1705. doi:10.14309/ajg.0000000000001943
   PubMedGoogle Scholar
• Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62(6):824–832. doi:10.1136/gutjnl-2012-302250
   PubMed Web of Science ®Google Scholar
• Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(1):13–22.e1. doi:10.1016/j.cgh.2015.07.041
   PubMed Web of Science ®Google Scholar
• Laserna-Mendieta EJ, Casabona S, Guagnozzi D, et al. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther. 2020;52(5):798–807. doi:10.1111/apt.15957
   PubMed Web of Science ®Google Scholar
• Muftah M, Goldin AH, Barshop K, et al. Twice-daily proton pump inhibitor induces higher remission rate in eosinophilic esophagitis than once-daily regimen regardless of total daily dose. Am J Gastroenterol. 2024;119:991–995. doi:10.14309/ajg.0000000000002712
   PubMedGoogle Scholar
• Laserna-Mendieta EJ, Navarro P, Casabona-Francés S, et al. Swallowed topical corticosteroids for eosinophilic esophagitis: utilization and real-world efficacy from the EoE CONNECT registry. Unit Europ Gastroenterol J. 2024;12:585–595. doi:10.1002/ueg2.12533
   PubMed Web of Science ®Google Scholar
• Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503–1512. doi:10.1016/0016-5085(95)90637-1
   PubMed Web of Science ®Google Scholar
• Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–1102. doi:10.1016/j.cgh.2006.05.026
   PubMed Web of Science ®Google Scholar
• Visaggi P, Mariani L, Pardi V, et al. Dietary management of eosinophilic esophagitis: tailoring the approach. Nutrients. 2021;13(5):1630. doi:10.3390/nu13051630
   PubMed Web of Science ®Google Scholar
• Arias A, Gonzalez-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639–1648. doi:10.1053/j.gastro.2014.02.006
   PubMed Web of Science ®Google Scholar
• Rank MA, Sharaf RN, Furuta GT, et al. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters. Anna Allergy Asthma Immunol. 2020;124(5):424–40.e17. doi:10.1016/j.anai.2020.03.021
   PubMed Web of Science ®Google Scholar
• Visaggi P, Baiano Svizzero F, Savarino E. Food elimination diets in eosinophilic esophagitis: practical tips in current management and future directions. Best Pract Res Clin Gastroenterol. 2023;101825. doi:10.1016/j.bpg.2023.101825
   PubMed Web of Science ®Google Scholar
• Molina-Infante J, Arias A, Alcedo J, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study. J Allergy Clin Immunol. 2018;141(4):1365–1372. doi:10.1016/j.jaci.2017.08.038
   PubMed Web of Science ®Google Scholar
• Mayerhofer C, Kavallar AM, Aldrian D, Lindner AK, Müller T, Vogel GF. Efficacy of elimination diets in eosinophilic esophagitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21(9):2197–210.e3. doi:10.1016/j.cgh.2023.01.019
   PubMed Web of Science ®Google Scholar
• Reed CC, Fan C, Koutlas NT, Shaheen NJ, Dellon ES. Food elimination diets are effective for long-term treatment of adults with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017;46(9):836–844. doi:10.1111/apt.14290
   PubMed Web of Science ®Google Scholar
• Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, Smout A, Bredenoord AJ. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113(6):836–844. doi:10.1038/s41395-018-0052-5
   PubMed Web of Science ®Google Scholar
• Gentile N, Katzka D, Ravi K, et al. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014;40(11–12):1333–1340. doi:10.1111/apt.12977
   PubMed Web of Science ®Google Scholar
• Aceves SS, Alexander JA, Baron TH, et al. Endoscopic approach to eosinophilic esophagitis: American society for gastrointestinal endoscopy consensus conference. Gastrointest Endosc. 2022;96(4):576–92.e1. doi:10.1016/j.gie.2022.05.013
   PubMed Web of Science ®Google Scholar
• Dougherty M, Runge TM, Eluri S, Dellon ES. Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86(4):581–91.e3. doi:10.1016/j.gie.2017.04.028
   PubMed Web of Science ®Google Scholar
• Kim JP, Weingart G, Hiramoto B, Gregory DL, Gonsalves N, Hirano I. Clinical outcomes of adults with eosinophilic esophagitis with severe stricture. Gastrointest Endosc. 2020;92(1):44–53. doi:10.1016/j.gie.2020.01.015
   PubMed Web of Science ®Google Scholar
• Madanick RD, Shaheen NJ, Dellon ES. A novel balloon pull-through technique for esophageal dilation in eosinophilic esophagitis (with video). Gastrointest Endosc. 2011;73(1):138–142. doi:10.1016/j.gie.2010.09.034
   PubMed Web of Science ®Google Scholar
• Schoepfer AM, Henchoz S, Biedermann L, et al. Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis. Gastrointest Endosc. 2021;94(5):912–9.e2. doi:10.1016/j.gie.2021.05.017
   PubMed Web of Science ®Google Scholar
• Pasha SF, Acosta RD, Chandrasekhara V, et al. The role of endoscopy in the evaluation and management of dysphagia. Gastrointest Endosc. 2014;79(2):191–201. doi:10.1016/j.gie.2013.07.042
   PubMed Web of Science ®Google Scholar
• Richter JE. Eosinophilic esophagitis dilation in the community--try it--you will like it--but start low and go slow. Am J Gastroenterol. 2016;111(2):214–216. doi:10.1038/ajg.2015.433
   PubMed Web of Science ®Google Scholar
• Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017;46(2):96–105. doi:10.1111/apt.14123
   PubMed Web of Science ®Google Scholar
• Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105(5):1062–1070. doi:10.1038/ajg.2009.657
   PubMed Web of Science ®Google Scholar
• Schupack DA, Ravi K, Geno DM, et al. Effect of maintenance therapy for eosinophilic esophagitis on need for recurrent dilation. Dig Dis Sci. 2021;66(2):503–510. doi:10.1007/s10620-020-06192-8
   PubMed Web of Science ®Google Scholar
• Safroneeva E, Cotton CC, Schoepfer AM, Zwahlen M, Woosley JT, Dellon ES. Dilation modifies association between symptoms and esophageal eosinophilia in adult patients with eosinophilic esophagitis. Am J Gastroenterol. 2020;115(12):2098–2102. doi:10.14309/ajg.0000000000000957
   PubMed Web of Science ®Google Scholar
• Larsson H, Strobel MJ, Perez-Guagnelli E. Emotional journey of patients with eosinophilic esophagitis. Adv Ther. 2023;40(12):5254–5270. doi:10.1007/s12325-023-02678-9
   PubMed Web of Science ®Google Scholar
• Ma C, Bredenoord AJ, Dellon ES, et al. Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointest Endosc. 2022;95(6):1126–37.e2. doi:10.1016/j.gie.2022.01.014
   PubMed Web of Science ®Google Scholar
• van Rhijn BD, Verheij J, Smout AJPM, Bredenoord AJ. The endoscopic reference score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis. Neurogastroenterol Motil. 2016;28(11):1714–1722. doi:10.1111/nmo.12872
   PubMed Web of Science ®Google Scholar
• Visaggi P, Solinas I, Baiano Svizzero F, et al. Non-invasive and minimally invasive biomarkers for the management of eosinophilic esophagitis beyond peak eosinophil counts: filling the gap in clinical practice. Diagnostics. 2023;13(17):1.
   Web of Science ®Google Scholar
• Eke R, Li T, White A, Tariq T, Markowitz J, Lenov A. Systematic review of histological remission criteria in eosinophilic esophagitis. JGH Open. 2018;2(4):158–165. doi:10.1002/jgh3.12059
   PubMedGoogle Scholar
• Collins MH, Martin LJ, Alexander ES, et al. Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. Dis Esophagus. 2016;30(3):1–8.
   Web of Science ®Google Scholar
• Whelan KA, Godwin BC, Wilkins B, et al. Persistent basal cell hyperplasia is associated with clinical and endoscopic findings in patients with histologically inactive eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2020;18(7):1475–82.e1. doi:10.1016/j.cgh.2019.08.055
   PubMed Web of Science ®Google Scholar
• Collins MH, Martin LJ, Wen T, et al. Eosinophilic esophagitis histology remission score: significant relations to measures of disease activity and symptoms. J Pediatr Gastroenterol Nutr. 2020;70(5):598–603. doi:10.1097/MPG.0000000000002637
   PubMed Web of Science ®Google Scholar
• Pouw RE, Barret M, Biermann K, et al. Endoscopic tissue sampling - Part 1: upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2021;53(11):1174–1188. doi:10.1055/a-1611-5091
   PubMed Web of Science ®Google Scholar
• Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10(7):742–9.e1. doi:10.1016/j.cgh.2012.03.018
   PubMed Web of Science ®Google Scholar
• Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas. 2018;9:353–367. doi:10.2147/PROM.S156279
   PubMed Web of Science ®Google Scholar
• Schoepfer A, Straumann A, Safroneeva E. Patient-Reported Outcomes in Eosinophilic Esophagitis and Achalasia. Curr Treat Options Gastroenterol. 2016;14(1):51–60. doi:10.1007/s11938-016-0084-0
   PubMedGoogle Scholar
• Dellon ES, Khoury P, Muir AB, et al. A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions. Gastroenterology. 2022;163:59–76. doi:10.1053/j.gastro.2022.03.025
   PubMed Web of Science ®Google Scholar
• Cotton CC, Moist SE, McGee SJ, Furuta GT, Aceves SS, Dellon ES. A newly proposed severity index for eosinophilic esophagitis is associated with baseline clinical features and successful treatment response. Clin Gastroenterol Hepatol. 2023;21(10):2534–42.e1. doi:10.1016/j.cgh.2023.03.047
   PubMed Web of Science ®Google Scholar
• Carlson DA, Gyawali CP, Roman S, et al. Esophageal hypervigilance and visceral anxiety are contributors to symptom severity among patients evaluated with high-resolution esophageal manometry. Am J Gastroenterol. 2020;115(3):367–375. doi:10.14309/ajg.0000000000000536
   PubMed Web of Science ®Google Scholar
• McCann E, Chehade M, Spergel JM, et al. Validation of the novel Eosinophilic Esophagitis Impact Questionnaire. J Patient Rep Outcomes. 2023;7(1):120. doi:10.1186/s41687-023-00654-z
   PubMedGoogle Scholar
• Taft TH, Kern E, Kwiatek MA, Hirano I, Gonsalves N, Keefer L. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment Pharmacol Ther. 2011;34(7):790–798. doi:10.1111/j.1365-2036.2011.04791.x
   PubMed Web of Science ®Google Scholar
• Martin LJ, Franciosi JP, Collins MH, et al. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. J Allergy Clin Immunol. 2015;135(6):1519–28.e8. doi:10.1016/j.jaci.2015.03.004
   PubMed Web of Science ®Google Scholar
• Butt MF, Visaggi P, Singh R, Vork L. Lack of awareness of neurogastroenterology and motility within medical education: time to fill the gap. Neurogastroenterol Motil. 2023;35(10):e14666. doi:10.1111/nmo.14666
   PubMed Web of Science ®Google Scholar
• Molina-Infante J. Nutritional and psychological considerations for dietary therapy in eosinophilic esophagitis. Nutrients. 2022;14(8). doi:10.3390/nu14081588
   PubMed Web of Science ®Google Scholar